Cargando…

Detection of oseltamivir‐resistant zoonotic and animal influenza A viruses using the rapid influenza antiviral resistance test

Mutations in the influenza virus neuraminidase (NA) that cause reduced susceptibility to the NA inhibitor (NAI) oseltamivir may occur naturally or following antiviral treatment. Currently, detection uses either a traditional NA inhibition assay or gene sequencing to identify known markers associated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hodges, Erin N., Mishin, Vasiliy P., De la Cruz, Juan, Guo, Zhu, Nguyen, Ha T., Fallows, Eric, Stevens, James, Wentworth, David E., Davis, Charles Todd, Gubareva, Larisa V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Short Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692545/ https://www.ncbi.nlm.nih.gov/pubmed/31187572 http://dx.doi.org/10.1111/irv.12661

Ejemplares similares

Monitoring influenza virus susceptibility to oseltamivir using a new rapid assay, iART
por: Gubareva, Larisa V, et al.
Publicado: (2017)

Cluster of Oseltamivir-Resistant and Hemagglutinin Antigenically Drifted Influenza A(H1N1)pdm09 Viruses, Texas, USA, January 2020
por: Mohan, Teena, et al.
Publicado: (2021)

Antiviral Drug–Resistant Influenza B Viruses Carrying H134N Substitution in Neuraminidase, Laos, February 2016
por: Baranovich, Tatiana, et al.
Publicado: (2017)

Susceptibility of Influenza A, B, C, and D Viruses to Baloxavir
por: Mishin, Vasiliy P., et al.
Publicado: (2019)

An Investigational Antiviral Drug, DAS181, Effectively Inhibits Replication of Zoonotic Influenza A Virus Subtype H7N9 and Protects Mice From Lethality
por: Marjuki, Henju, et al.
Publicado: (2014)

Detection of baloxavir resistant influenza A viruses using next generation sequencing and pyrosequencing methods
por: Patel, Mira C., et al.
Publicado: (2020)

Susceptibility of widely diverse influenza a viruses to PB2 polymerase inhibitor pimodivir
por: Patel, Mira C., et al.
Publicado: (2021)

Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011–2018
por: Jorquera, Patricia A., et al.
Publicado: (2019)

Oseltamivir-Resistant Influenza A(H1N1)pdm09 Viruses, United States, 2013–14
por: Okomo-Adhiambo, Margaret, et al.
Publicado: (2015)

Oseltamivir resistance in swine influenza: a brief discussion
por: Wiwanitkit, Viroj
Publicado: (2009)

An optimized cell-based assay to assess influenza virus replication by measuring neuraminidase activity and its applications for virological surveillance
por: Patel, Mira C., et al.
Publicado: (2022)

745. Surveillance for Oseltamivir-Resistant Influenza A(H1N1)pdm09 Virus Infections During 2016–2017 and 2017–2018, United States
por: Spencer, Sarah, et al.
Publicado: (2018)

Antiviral susceptibility of clade 2.3.4.4b highly pathogenic avian influenza A(H5N1) viruses isolated from birds and mammals in the United States, 2022
por: Nguyen, Ha T., et al.
Publicado: (2023)

Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins
por: Marjuki, Henju, et al.
Publicado: (2016)

Antiviral Susceptibility of Highly Pathogenic Avian Influenza A(H5N1) Viruses Isolated from Poultry, Vietnam, 2009–2011
por: Nguyen, Ha T., et al.
Publicado: (2013)

Interferon Lambda Delays the Emergence of Influenza Virus Resistance to Oseltamivir
por: Medaglia, Chiara, et al.
Publicado: (2021)

Triple Combination Antiviral Drug (TCAD) Composed of Amantadine, Oseltamivir, and Ribavirin Impedes the Selection of Drug-Resistant Influenza A Virus
por: Hoopes, Justin D., et al.
Publicado: (2011)

Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations
por: Davies, Brian E.
Publicado: (2010)

Clinical and virologic outcomes in patients with oseltamivir‐resistant seasonal influenza A (H1N1) infections: results from a clinical trial
por: Dharan, Nila J., et al.
Publicado: (2011)

Antiviral Oseltamivir Is not Removed or Degraded in Normal Sewage Water Treatment: Implications for Development of Resistance by Influenza A Virus
por: Fick, Jerker, et al.
Publicado: (2007)

Detection of Resistance Mutations to Antivirals Oseltamivir and Zanamivir in Avian Influenza A Viruses Isolated from Wild Birds
por: Orozovic, Goran, et al.
Publicado: (2011)

Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the Influenza Resistance Information Study
por: Lina, Bruno, et al.
Publicado: (2018)

Neuraminidase Inhibitor Susceptibility Testing in Human Influenza Viruses: A Laboratory Surveillance Perspective
por: Okomo-Adhiambo, Margaret, et al.
Publicado: (2010)

Simultaneous Detection of Oseltamivir- and Amantadine-Resistant Influenza by Oligonucleotide Microarray Visualization
por: Zhang, Yingjie, et al.
Publicado: (2013)

Assessing baloxavir susceptibility of influenza viruses circulating in the United States during the 2016/17 and 2017/18 seasons
por: Gubareva, Larisa V, et al.
Publicado: (2019)

INFLUENZA VIRUS SURVEILLANCE BY THE INSTITUTO ADOLFO LUTZ, INFLUENZA SEASON 2014: ANTIVIRAL RESISTANCE
por: Santos, Katia Corrêa de Oliveira, et al.
Publicado: (2015)

Oseltamivir (Tamiflu(®)) in the environment, resistance development in influenza A viruses of dabbling ducks and the risk of transmission of an oseltamivir-resistant virus to humans – a review
por: Järhult, Josef D.
Publicado: (2012)

Oseltamivir- and Amantadine-Resistant Influenza Virus A (H1N1)
por: Cheng, Peter K.C., et al.
Publicado: (2010)

Oseltamivir- and Amantadine-Resistant Influenza Viruses A (H1N1)
por: Cheng, Peter K.C., et al.
Publicado: (2009)

Assessing the oseltamivir-induced resistance risk and implications for influenza infection control strategies
por: Hsieh, Nan-Hung, et al.
Publicado: (2017)

Influenza and antiviral resistance: an overview
por: Lampejo, Temi
Publicado: (2020)

Oseltamivir in human avian influenza infection
por: Smith, James R.
Publicado: (2010)

Outbreak of Antiviral Drug–Resistant Influenza A in Long-Term Care Facility, Illinois, USA, 2008
por: Dharan, Nila J., et al.
Publicado: (2009)

Sales of oseltamivir in Norway prior to the emergence of oseltamivir resistant influenza A(H1N1) viruses in 2007–08
por: Hauge, Siri H, et al.
Publicado: (2009)

A Therapeutically Active Minibody Exhibits an Antiviral Activity in Oseltamivir-Resistant Influenza-Infected Mice via Direct Hydrolysis of Viral RNAs
por: Lee, Yongjun, et al.
Publicado: (2022)

Oseltamivir-Resistant Influenza Viruses A (H1N1) during 2007–2009 Influenza Seasons, Japan
por: Ujike, Makoto, et al.
Publicado: (2010)

Influenza antivirals and animal models
por: Caceres, C. Joaquin, et al.
Publicado: (2022)

Correction: Okomo-Adhiambo, M. et al. Neuraminidase Inhibitor Susceptibility Testing in Human Influenza Viruses: A Laboratory Surveillance Perspective. Viruses 2010, 2, 2269–2289
por: Okomo-Adhiambo, Margaret, et al.
Publicado: (2011)

Antiviral Resistance and the Control of Pandemic Influenza
por: Lipsitch, Marc, et al.
Publicado: (2007)

Clinical Implications of Antiviral Resistance in Influenza
por: Li, Timothy C. M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_sbs204ht7nc7l57i8a2nc7394d